Article Correctness Is Author's Responsibility: A Potential Biomarker for Predicting Antibody Treatment Efficacy in Migraine

The article below may contain offensive and/or incorrect content.

Researchers showed high migraine induction capabilities with calcitonin gene-related peptide (CGRP) in people with migraine who responded to erenumab treatment compared to data from previous CGRP provocation experiments.